News & Analysis as of

Pharmaceutical Industry Citigroup

Robins Kaplan LLP

Your Daily Dose of Financial News

Robins Kaplan LLP on

As expected based on buzz from late last week, longtime CBS chief Les Moonves is out at the network he’s led for more than 20 years.  While his exit has been in the works for some time, a report out yesterday detailing new...more

Robins Kaplan LLP

Your Daily Dose of Financial News

Robins Kaplan LLP on

Theranos founder and ex-CEO Elizabeth Holmes has been indicted on federal fraud charges along with former company president Ramesh Balwani.  The charges come three months after Holmes settled civil charges with the SEC....more

Robins Kaplan LLP

Your Daily Dose of Financial News

Robins Kaplan LLP on

Takeda has officially emerged victorious in the battle for Shire. The Japanese drug giant will pay more than $66/share to acquire Shire in a deal valued at $62 billion....more

Robins Kaplan LLP

Your Daily Dose of Financial News

Robins Kaplan LLP on

HSBC’s making good on its plans to shift to a focus on Asia by naming John Flint—who spent his first 14 years at the bank in Asia—as its new CEO. Flint will take over from Stuart Gulliver in February....more

Robins Kaplan LLP

Your Daily Dose of Financial News

Robins Kaplan LLP on

The CFTC’s reportedly investigating the interest rate swap activities of Citigroup and others. Swaps allow companies to “hedge against a rise or fall in interest rates on the debt that they issue or hold, with banks usually...more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide